IN8bio, Inc. (NASDAQ:INAB – Free Report) – Research analysts at Zacks Small Cap cut their FY2024 earnings per share estimates for IN8bio in a research note issued on Monday, May 20th. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.62) per share for the year, down from their prior estimate […]